Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) stays active in your body for approximately a week after each dose, which means the precise hour you choose for your weekly injection has less clinical impact than you might expect. Official guidance, including the NHS tirzepatide medicines page, confirms you can take it at any time of day, with or without food. What matters far more is consistency: picking a day and sticking to it. As a prescription-only medicine, Mounjaro requires clinical assessment before it can be prescribed, and your prescriber can help you build a routine that actually fits your week.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's long half-life is the starting point for any honest answer here. At roughly five days, the medicine is still present and active well into the following week — which is precisely why once-weekly dosing works at all. The SURMOUNT-1 trial, which enrolled around 2,500 adults with obesity over 72 weeks, did not require participants to inject at a fixed time of day, and the results still showed average body-weight reductions of around 20–21% at the 15 mg dose. The published trial paper in the New England Journal of Medicine confirms that the protocol left time-of-day flexible.
In practical terms this means the question of AM versus PM, before breakfast versus after dinner, is not a clinically significant one. The body does not experience a meaningful difference in tirzepatide exposure based on whether you inject at seven in the morning or nine at night. What the evidence does support is keeping the interval between doses close to seven days. Drift that interval consistently short or long and you are either doubling up exposure or creating a gap where levels fall, neither is ideal.
So the real evidence-based instruction is simple: pick a day, not a time.
This is where real-world behaviour matters more than pharmacology. A day that sounds sensible in a consultation can quietly become the hardest day of the week. Midweek days tend to work well for people who travel for work at weekends. Saturdays suit those whose mornings are more relaxed then. Some people anchor the injection to an existing ritual: the gym session, the Sunday meal prep, the first coffee of the week.
One thing worth noting: monthly rhythms catch people out. Payday falls on different calendar days each month, school holidays shuffle routines, and bank-holiday weekends mean the pen sometimes stays in the fridge an extra day. Because Mounjaro allows up to three days of flexibility in either direction, a bank-holiday shift is generally fine, but the Patient Information Leaflet sets out exactly what to do, and your prescriber is the right person to ask if you are unsure about a longer gap.
If you are considering Mounjaro for the first time and want to understand how long before any effect becomes noticeable, our page on how long Mounjaro takes to work covers the evidence on onset and early response in more detail. Separately, if you have come across references to an oral form of tirzepatide, our page on the tirzepatide pill explains what is currently known about this format and the UK licensing position clearly.
There is no clinical winner between morning and evening injections. That said, there are practical patterns worth knowing. Some people prefer mornings because the dose is done before the day gets complicated. Others find evenings easier because any nausea that can follow a new dose or a step-up largely passes overnight rather than during working hours. The nausea, where it occurs, tends to be most pronounced in the first day or two after each pen advance, particularly when moving from one dose level to the next.
NICE's appraisal of tirzepatide (TA1026) notes that the medicine is recommended for adults with a BMI of 35 or above alongside at least one weight-related condition, with lower thresholds applying for some ethnic backgrounds under UK guidance. Eligibility is assessed by the prescriber, not self-declared, and the process includes reviewing your full clinical picture. The cost of private treatment varies by dose and provider; for a grounded picture of what a legitimate private prescription involves, the weight-loss treatments page sets out what is included at each stage.
Mounjaro is a prescription-only medicine. A clinician reviews suitability before any prescription is issued, a step that also gives you the chance to talk through timing, rotation and what to expect in the first few weeks. Our Mounjaro overview covers the broader picture if you want the full context before that conversation.
Once you have settled on a day, storage becomes part of the rhythm. Mounjaro pens are kept refrigerated at 2–8°C; the Patient Information Leaflet specifies a limited window during which a pen can be kept at room temperature if needed, and that is the document to follow for exact figures rather than any general online source. If you have been reading about non-injectable formats and want to know whether Mounjaro is available in pill form and how that differs from the current injection in terms of how the medicine is delivered and absorbed, that page sets out what the research currently shows. Keeping the pen in a consistent spot in the fridge (away from the freezer compartment) means it is there when you need it.
If your usual day genuinely cannot work one week, the three-day window means you have some room to move. Take the injection as soon as you remember if a dose is late, then carry on from that new day. Never take two doses to compensate. For anything more complicated (a surgical procedure, a course of antibiotics, a period of illness with vomiting) the right call is to contact your prescriber rather than adjust independently. Our FAQs address a number of common missed-dose and routine questions, and questions about emerging formats such as the Mounjaro oral pill are also covered there for those curious about what future options might look like. Our support team is available seven days a week if something specific comes up between reviews.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.